The second mutated gene in S1 was CDH17, which has been shown to promote tumorigenesis and metastasis through Wnt-signaling [22] and the third, the LMLN gene, which encodes a zinc-metallopeptidase, has not previously been implicated in cancer. The gene discussed is CDH17; the disease is cancer.